Effects of the NMDA-receptor antagonist ketamine on perceptual correlates of long-term potentiation within the nociceptive system

Neuropharmacology

Volumn 52, Issue 2, 2007, Pages 655-661

  Klein, Thomas ^a   Magerl, Walter ^a   Nickel, Ursula ^a   Hopf, Hanns Christian ^a   Sandkühler, Jürgen ^b   Treede, Rolf Detlef ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Medical University of Vienna   (Austria)

Author keywords

Central sensitization; Hyperalgesia; Neuropathic pain; Pain; Pain memory; Spinal cord

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONDITIONING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; FACILITATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; LONG TERM POTENTIATION; LOW DRUG DOSE; MALE; MEMORY; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NOCICEPTION; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; SPINAL CORD; STATISTICAL ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPERALGESIA; KETAMINE; LONG-TERM POTENTIATION; MALE; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; REACTION TIME;

EID: 33846296546     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.09.008     Document Type: Article

References (43)

1. Bailey C.H., Giustetto M., Huang Y.-Y., Hawkins R.D., and Kandel E.R. Is heterosynaptic modulation essential for stabilizing Hebbian plasticity and memory?. Nature Reviews Neuroscience 1 (2000) 11-20
2. Benrath J., Brechtel C., Stark J., and Sandkuhler J. Low dose of S+-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo. British Journal of Anaesthesia 95 (2005) 518-523
3. Bliss T.V.P., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
4. Cervero F., and Laird J.M.A. One pain or many pains? A new look at pain mechanisms. News in Physiological Sciences 6 (1991) 268-273
5. Chizh B.A., Cumberbatch M.J., Herrero J.F., Stirk G.C., and Headley P.M. Stimulus intensity, cell excitation and the N-methyl-d-aspartate receptor component of sensory responses in the rat spinal cord in vivo. Neuroscience 80 (1997) 251-265
6. Greenspan J.D., and McGillis S.L.B. Thresholds for the perception of pressure, sharpness, and mechanically evoked cutaneous pain: effects of laterality and repeated testing. Somatosensory and Motor Research 11 (1994) 311-317
7. Hirota K., and Lambert D.G. Ketamine: its mechanism(s) of action and unusual clinical uses. British Journal of Anaesthesia 77 (1996) 441-444
8. Hu X.D., Ge Y.X., Hu N.W., Zhang H.M., Zhou L.J., Zhang T., Li W.M., Han Y.F., and Liu X.G. Diazepam inhibits the induction and maintenance of LTP of C-fiber evoked field potentials in spinal dorsal horn of rats. Neuropharmacology 50 (2006) 238-244
9. Ikeda H., Heinke B., Ruscheweyh R., and Sandkühler J. Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299 (2003) 1237-1240
10. Ilkjaer S., Petersen K.L., Brennum J., Wernberg M., and Dahl J.B. Effect of systemic N-methyl-d-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. British Journal of Anaesthesia 76 (1996) 829-834
11. Ji R.-R., Kohno T., Moore K.A., and Woolf C.J. Central sensitization and LTP: do pain and memory share similar mechanisms?. Trends in Neurosciences 26 (2003) 696-705
12. Klein T., Magerl W., Hopf H.C., Sandkühler J., and Treede R.-D. Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans. Journal of Neuroscience 24 (2004) 964-971
13. Kochs E., Scharein E., Möllenberg O., Bromm B., and Schulte am Esch J. Analgesic efficacy of low-dose ketamine: somatosensory-evoked responses in relation to subjective pain ratings. Anesthesiology 85 (1996) 304-314
14. Kohrs R., and Durieux M.E. Ketamine: teaching an old drug new tricks. Anesthesia and Analgesia 87 (1998) 1186-1193
15. Koppert W., Dern S.K., Sittl R., Albrecht S., Schuttler J., and Schmelz M. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology 95 (2001) 395-402
16. Laird J.M.A., Delarubia P.G., and Cervero F. Excitability changes of somatic and viscero-somatic nociceptive reflexes in the decerebrate-spinal rabbit: role of NMDA receptors. The Journal of Physiology 489 (1995) 545-555
17. Laird J.M.A., Roza C., DeFelipe C., Hunt S.P., and Cervero F. Role of central and peripheral tachykinin NK1 receptors in capsaicin-induced pain and hyperalgesia in mice. Pain 90 (2001) 97-103
18. Leem J.W., Willis W.D., Weller S.C., and Chung J.M. Differential activation and classification of cutaneous afferents in the rat. Journal of Neurophysiology 70 (1993) 2411-2424
19. Liu X.G., and Sandkühler J. Long-term potentiation of C-fiber-evoked potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-d-aspartic acid receptor blockage. Neuroscience Letters 191 (1995) 43-46
20. Liu X.G., and Sandkühler J. Characterization of long-term potentiation of C-fiber-evoked potentials in spinal dorsal horn of adult rat: essential role of NK1 and NK2 receptors. Journal of Neurophysiology 78 (1997) 1973-1982
21. Magerl W., Fuchs P.N., Meyer R.A., and Treede R.-D. Roles of capsaicin-insensitive nociceptors in pain and secondary hyperalgesia. Brain 124 (2001) 1754-1764
22. Magerl W., Wilk S.H., and Treede R.-D. Secondary hyperalgesia and perceptual wind-up following intradermal injection of capsaicin in humans. Pain 74 (1998) 257-268
23. Malcangio M., and Lessmann V. A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends in Pharmacological Sciences 24 (2003) 116-121
24. Mikkelsen S., Ilkjaer S., Brennum J., Borgbjerg F.M., and Dahl J.B. The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans. Anesthesiology 90 (1999) 1539-1545
25. Park K.M., Max M.B., Robinovitz E., Gracely R.H., and Bennett G.J. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 63 (1995) 163-172
26. Parsons C.G. NMDA receptors as targets for drug action in neuropathic pain. European Journal of Pharmacology 429 (2001) 71-78
27. Rammes G., Rupprecht R., Ferrari U., Zieglgänsberger W., and Parsons C.G. The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neuroscience Letters 306 (2001) 81-84
28. Randic M., Jiang M.C., and Cerne R. Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord. Journal of Neuroscience 13 (1993) 5228-5241
29. Sandkühler J. Learning and memory in pain pathways. Pain 88 (2000) 113-118
30. Schulte H., Sollevi A., and Segerdahl M. The synergistic effect of combined treatment with systemic ketamine and morphine on experimentally induced windup-like pain in humans. Anesthesia and Analgesia 98 (2004) 1574-1580
31. Stubhaug A., Breivik H., Eide P.K., Kreunen M., and Foss A. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiologica Scandinavica 41 (1997) 1124-1132
32. Sun R.-Q., Lawand N.B., Lin Q., and Willis W.D. Role of calcitonin gene-related peptide in the sensitization of dorsal horn neurons to mechanical stimulation after intradermal injection of capsaicin. Journal of Neurophysiology 92 (2004) 320-326
33. Suzuki R., Morcuende S., Webber M., Hunt S.P., and Dickenson A.H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nature Neuroscience 5 (2002) 1319-1326
34. Svendsen F., Tjolsen A., and Hole K. AMPA and NMDA receptor-dependent spinal LTP after nociceptive tetanic stimulation. Neuroreport 9 (1998) 1185-1190
35. Terayama R., Guan Y., Dubner R., and Ren K. Activity-induced plasticity in brain stem pain modulatory circuitry after inflammation. Neuroreport 11 (2000) 1915-1919
36. Terman G.W., Eastman C.L., and Chavkin C. Mu opiates inhibit long-term potentiation induction in the spinal cord slice. Journal of Neurophysiology 85 (2001) 485-494
37. Treede R.-D., and Magerl W. Modern concepts of pain and hyperalgesia: beyond the polymodal C-nociceptor. News in Physiological Sciences 10 (1995) 216-228
38. Wallace M.S., Ridgeway B., Leung A., Schulteis G., and Yaksh T.L. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia. Journal of Clinical Pharmacology 42 (2002) 70-80
39. Walters E.T. Injury-related behavior and neuronal plasticity: an evolutionary perspective on sensitization, hyperalgesia, and analgesia. International Review of Neurobiology 36 (1994) 325-427
40. Willis W.D. Long-term potentiation in spinothalamic neurons. Brain Research Reviews 40 (2002) 202-214
41. Yang H.W., Zhou L.J., Hu N.W., Xin W.J., and Liu X.G. Activation of spinal D1/D5 receptors induces late-phase LTP of C-fiber-evoked field potentials in rat spinal dorsal horn. Journal of Neurophysiology 94 (2005) 961-967
42. Zeitz K.P., Guy N., Malmberg A.B., Dirajlal S., Martin W.J., Sun L., Bonhaus D.W., Stucky C.L., Julius D., and Basbaum A.I. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. Journal of Neuroscience 22 (2002) 1010-1019
43. Ziemann U., Tergau F., Bruns D., Baudewig J., and Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalography Clinical Neurophysiology 105 (1997) 430-437